Buy­out buzz: No­var­tis has been kick­ing the tires at AAA as FDA re­views Lu­tathera — re­port

Af­ter work­ing through some sna­fus on its ap­pli­ca­tions for its ex­per­i­men­tal can­cer drug Lu­tathera, Bloomberg is re­port­ing that No­var­tis has been kick­ing the tires at France’s Ad­vanced Ac­cel­er­a­tor ap­pli­ca­tions with an in­ter­est in mak­ing a bid for the com­pa­ny.

No one is say­ing that No­var­tis has bid for the com­pa­ny, and Bloomberg’s piece notes that oth­ers may step in — the kind of sto­ry that nev­er hurts your stock price $AAAP.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER